| Original language | English (US) |
|---|---|
| Pages (from-to) | 860 |
| Number of pages | 1 |
| Journal | The Lancet |
| Volume | 328 |
| Issue number | 8511 |
| DOIs | |
| State | Published - Oct 11 1986 |
| Externally published | Yes |
Fingerprint
Neoplasm Antibodies
Antibodies
Neoplasms
Therapeutics
ASJC Scopus subject areas
- Medicine(all)
Cite this
Vaughan, A. T. M., Chapman, C., Dykes, P. W., Anderson, P., & Bradwell, A. R. (1986). ANTIBODY-TARGETED THERAPY OF CANCER. The Lancet, 328(8511), 860. https://doi.org/10.1016/S0140-6736(86)92891-6
ANTIBODY-TARGETED THERAPY OF CANCER. / Vaughan, Andrew T M; Chapman, C.; Dykes, P. W.; Anderson, P.; Bradwell, A. R.
In: The Lancet, Vol. 328, No. 8511, 11.10.1986, p. 860.Research output: Contribution to journal › Article
Vaughan, ATM, Chapman, C, Dykes, PW, Anderson, P & Bradwell, AR 1986, 'ANTIBODY-TARGETED THERAPY OF CANCER', The Lancet, vol. 328, no. 8511, pp. 860. https://doi.org/10.1016/S0140-6736(86)92891-6
Vaughan ATM, Chapman C, Dykes PW, Anderson P, Bradwell AR. ANTIBODY-TARGETED THERAPY OF CANCER. The Lancet. 1986 Oct 11;328(8511):860. https://doi.org/10.1016/S0140-6736(86)92891-6
@article{9e8a3d3c9f794ded99799c80ae7d9138,
title = "ANTIBODY-TARGETED THERAPY OF CANCER",
author = "Vaughan, {Andrew T M} and C. Chapman and Dykes, {P. W.} and P. Anderson and Bradwell, {A. R.}",
year = "1986",
month = "10",
day = "11",
doi = "10.1016/S0140-6736(86)92891-6",
language = "English (US)",
volume = "328",
pages = "860",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8511",
}
TY - JOUR
T1 - ANTIBODY-TARGETED THERAPY OF CANCER
AU - Vaughan, Andrew T M
AU - Chapman, C.
AU - Dykes, P. W.
AU - Anderson, P.
AU - Bradwell, A. R.
PY - 1986/10/11
Y1 - 1986/10/11
UR - http://www.scopus.com/inward/record.url?scp=0022978473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022978473&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(86)92891-6
DO - 10.1016/S0140-6736(86)92891-6
M3 - Article
C2 - 2876299
AN - SCOPUS:0022978473
VL - 328
SP - 860
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 8511
ER -